Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 18.5 | 46 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 20.5 | 38 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 16.0 | 51 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 21.0 | 53 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 24.0 | 51 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 22.0 | 45 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 22.0 | 39 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | IL18 | 21.0 | 37 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL18 | 30.0 | 47 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | IL18 | 27.0 | 58 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL18 | 18.0 | 53 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | IL18 | 19.0 | 59 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL18 | 28.0 | 41 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | IL18 | 26.0 | 65 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | IL18 | 21.5 | 68 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL18 | 20.0 | 37 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | IL18 | 26.0 | 51 | ||||
RA1869 | 1 | IL18 | 23.0 | 51 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | IL18 | 20.0 | 52 | ||||
N2759 | 1 | IL18 | 18.0 | 59 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | IL18 | 28.0 | 45 | ||||
RA1931 | 1 | IL18 | 29.0 | 45 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL18 | 21.5 | 46 | ||||
N2586 | 1 | IL18 | 23.0 | 49 | |||||||
0 | IL18 | 17.0 | 61 |